|
|
![]() |
![]() |
![]() |
![]() |
|
![]() |
|
![]() |
|
![]() |
|
![]() |
![]() |
![]() |
|
![]() |
|||||||||||||||||||||||||||||||||||||||||||||
| Sponsored by: |
National Heart, Lung, and Blood Institute (NHLBI) |
| Information provided by: | National Heart, Lung, and Blood Institute (NHLBI) |
| ClinicalTrials.gov Identifier: | NCT00005270 |
Purpose
To map the major genetic loci underlying hypertension in approximately 1700 sibling pairs of Asian-Pacific Chinese and Japanese origin. The study consists of a two grant network, which in turn is part of an NHLBI initiative, the Family Blood Pressure Program (FBPP) consisting of four networks.
| Condition | Phase |
|
Cardiovascular Diseases Heart Diseases Hypertension |
N/A |
| MedlinePlus related topics: | Heart Diseases High Blood Pressure |
| Drug Information available for: | Aluminum oxide |
| Study Type: | Observational |
| Study Start Date: | September 1995 |
| Study Completion Date: | August 2008 |
| Primary Completion Date: | August 2008 (Final data collection date for primary outcome measure) |
![]() |
Show Detailed Description |
Eligibility
| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | No |
No eligibility criteria
Contacts and Locations
More Information
| Study ID Numbers: | 1154 |
| First Received: | May 25, 2000 |
| Last Updated: | August 20, 2008 |
| ClinicalTrials.gov Identifier: | NCT00005270 |
| Health Authority: | United States: Federal Government |
|
|